Cosmo spinout Cassiopea wins FDA approval for new acne drug
A small Swiss-listed biotech spinout secured FDA approval for their first drug, setting them up to compete in a crowded market for acne.
Cassiopea received …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
